Published in J Neurochem on April 01, 1978
Tetanus toxin. Microbiol Rev (1979) 2.25
Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol (2001) 1.85
Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences. Exp Neurol (1997) 1.61
A long-term follow-up of botulinum toxin A in cervical dystonia. Neurol Res (2009) 1.17
Gangliosides in nervous tissue cultures and binding of 125I-labelled tetanus toxin, a neuronal marker. J Neurochem (1977) 1.08
Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers. Eur J Clin Pharmacol (1994) 1.01
Tetanus toxin blocks the neuromuscular transmission in vitro like botulinum A toxin. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.99
Tetanus toxin and botulinum A toxin inhibit release and uptake of various transmitters, as studied with particulate preparations from rat brain and spinal cord. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.99
Botulinum A toxins: units versus units. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.98
Pharmacology of botulinum toxin: differences between type A preparations. Eur J Neurol (2006) 0.97
Differential effects of tetanus toxin on inhibitory and excitatory synaptic transmission in mammalian spinal cord neurons in culture: a presynaptic locus of action for tetanus toxin. J Neurophysiol (1987) 0.96
Effect of the external nasal dilator Breathe Right on snoring. Eur J Med Res (1998) 0.91
Nerve conduction changes and fine structural alterations of extra- and intrafusal muscle and nerve fibers in streptozotocin diabetic rats. Muscle Nerve (1995) 0.91
Botulinum A neurotoxin inhibits non-cholinergic synaptic transmission in mouse spinal cord neurons in culture. Brain Res (1985) 0.91
Molecular aspects of tetanus and botulinum neurotoxin poisoning. Prog Neurobiol (1995) 0.90
IgA protease from Neisseria gonorrhoeae inhibits exocytosis in bovine chromaffin cells like tetanus toxin. J Biol Chem (1995) 0.90
Botulinum A neurotoxin unlike tetanus toxin acts via a neuraminidase sensitive structure. Toxicon (1986) 0.88
Differential effects of various secretagogues on quantal transmitter release from mouse motor nerve terminals treated with botulinum A and tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.88
Botulinum toxin antibody testing: comparison between the mouse protection assay and the mouse lethality assay. Mov Disord (2000) 0.88
Tetanus toxin in dissociated spinal cord cultures: long-term characterization of form and action. J Neurochem (1986) 0.87
The influence of electromagnetic fields on human brain activity. Eur J Med Res (1995) 0.87
Binding characteristics of 125I-labelled tetanus toxin to primary tissue cultures from mouse embryonic CNS. J Neurochem (1977) 0.86
Botulinum neurotoxin - from laboratory to bedside. Neurotox Res (2006) 0.86
Botulism type B presenting as pure autonomic dysfunction. Clin Auton Res (2003) 0.85
Quantitative EEG and BPRS data following Haldol-Decanoate administration in schizophrenics. Int Clin Psychopharmacol (1994) 0.85
Suppression of 3H-acetylcholine release from primary nerve cell cultures by tetanus and botulinum-A toxin. Naunyn Schmiedebergs Arch Pharmacol (1978) 0.85
Tetanus toxin: inhibitory action in chromaffin cells is initiated by specified types of gangliosides and promoted in low ionic strength solution. Neurosci Lett (1989) 0.82
Gangliosides mediate inhibitory effects of tetanus and botulinum A neurotoxins on exocytosis in chromaffin cells. Toxicon (1989) 0.82
Relation between psychometric tests and quantitative topographic EEG in pharmacology. Int J Clin Pharmacol Ther Toxicol (1992) 0.81
Blockade by tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. Naunyn Schmiedebergs Arch Pharmacol (1980) 0.81
Secondary non-response due to development of neutralising antibodies to botulinum toxin A during treatment of children with cerebral palsy. Neuropediatrics (2000) 0.81
125I-Labelled tetanus toxin as a neuronal marker in tissue cultures derived from embryonic CNS. Naunyn Schmiedebergs Arch Pharmacol (1975) 0.81
Tetanus and botulinum A toxins inhibit stimulated F-actin rearrangement in chromaffin cells. Neuroreport (1991) 0.81
Hyperexcitability of cultured central nervous system neurons caused by tetanus toxin. Exp Neurol (1979) 0.81
Interaction of labelled tetanus toxin with substructures of rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.81
Pharmacodynamic effects of valerian and hops extract combination (Ze 91019) on the quantitative-topographical EEG in healthy volunteers. Eur J Med Res (2000) 0.80
Distinct targets for tetanus and botulinum A neurotoxins within the signal transducing pathway in chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.80
Radioelectroencephalography (Tele-Stereo-EEG) in the rat as a pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital. Neuropsychobiology (1986) 0.80
Multiunit activity from the A9 and A10 areas in rats following chronic treatment with different neuroleptic drugs. Eur Neuropsychopharmacol (1994) 0.80
Inhibition of synaptosomal choline uptake by tetanus and botulinum A toxin. Partial dissociation of fixation and effect of tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.80
Classification of drugs by stereotactic recording of focal brain activity in the rat (stereo-EEG). Neuropsychobiology (1984) 0.80
Reflection of mental exercise in the dynamic quantitative topographical EEG. Neuropsychobiology (1995) 0.80
Effect of gangliosides on nerve conduction velocity during diabetic neuropathy in the rat. Arch Int Pharmacodyn Ther (1987) 0.79
Tetanus antitoxin binds to intracellular tetanus toxin in permeabilized chromaffin cells without restoring Ca2(+)-induced exocytosis. Toxicon (1990) 0.79
Depletion of neutralising antibodies resensitises a secondary non-responder to botulinum A neurotoxin. J Neurol Neurosurg Psychiatry (1998) 0.79
Results of a BoNT/A antibody study in children and adolescents after onabotulinumtoxin A (Botox®) detrusor injection. Urol Int (2011) 0.79
Specific antibodies against the Zn(2+)-binding domain of clostridial neurotoxins restore exocytosis in chromaffin cells treated with tetanus or botulinum A neurotoxin. J Biol Chem (1994) 0.78
Pathophysiology and psychopharmacology of dementia--a new study design. I. Diagnosis comprising subjective and objective criteria. Neuropsychobiology (1995) 0.78
The sternocleidomastoid test: an in vivo assay to investigate botulinum toxin antibody formation in humans. J Neurol (2000) 0.78
Uptake of antitetanus F(ab')2 fragments into eukaryotic cells. J Physiol (Paris) (1990) 0.78
Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG. Pharmacopsychiatry (1998) 0.78
Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.78
Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study. Eur Neurol (2000) 0.78
Electrophysiological studies on the effects of the neurotoxin apamin on cultured neurons. Adv Cytopharmacol (1979) 0.77
Distribution of 125 I-tetanus toxin and 125 I-toxoid in rats with generalized tetanus, as influenced by antitoxin. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.77
Tetanus toxin and botulinum A toxin inhibit acetylcholine release from but not calcium uptake into brain tissue. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.77
Microelectrode measurement of cell membrane potential in isolated hepatocytes attached to collagen. Biochim Biophys Acta (1986) 0.77
The translocation of botulinum A neurotoxin by chromaffin cells is promoted in low ionic strength solution and is insensitive to trypsin. Toxicon (1991) 0.77
'Fingerprints' of central stimulatory drug effects by means of quantitative radioelectroencephalography in the rat (tele-stereo-EEG). Neuropsychobiology (1986) 0.76
Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia. Neurol Clin Neurophysiol (2001) 0.76
Normal and pseudorabies virus infected primary nerve cell cultures in scanning electron microscopy. Med Microbiol Immunol (1979) 0.76
Carbamazepine blocks NMDA-activated currents in cultured spinal cord neurons. Neuroreport (1990) 0.76
Evidence for neuronal dysfunction in migraine: concurrence between specific qEEG findings and clinical drug response--a retrospective analysis-. Eur J Med Res (2000) 0.76
Acid secretion of parietal cells is paralleled by a redistribution of NSF and alpha, beta-SNAPs and inhibited by tetanus toxin. Histochem Cell Biol (2000) 0.76
Treatment of habitual snoring with botulinum toxin: a pilot study. Sleep Breath (2008) 0.75
Restoration of exocytosis occurs after inactivation of intracellular tetanus toxin. Infect Immun (1992) 0.75
Drug-induced field potential changes in dopaminergic target areas after electrical stimulation of the rat mesencephalon. Neuropsychobiology (1985) 0.75
Modulation of glycine-activated membrane current by adamantane derivatives. Neuroreport (1991) 0.75
Mammalian nerve cell culture. Methods Enzymol (1981) 0.75
SNARE proteins and rab3A contribute to canalicular formation in parietal cells. Eur J Cell Biol (1999) 0.75
Pathophysiology and psychopharmacology of dementia--a new study design. 2. Cyclandelate treatment--a placebo-controlled double-blind clinical trial. Neuropsychobiology (1997) 0.75
Morphological and electrophysiological aspects of dissociated cultures of rat CNS. Arch Toxicol (1983) 0.75
Functional imaging of headache - first steps in an objective quantitative classification of migraine. Eur J Med Res (1997) 0.75
Studies of gangliosides in diverse nerve cell cultures. Adv Exp Med Biol (1984) 0.75
Action of botulinum A toxin and tetanus toxin on synaptic transmission. J Physiol (Paris) (1984) 0.75
Classification of sulpiride, clozapine and haloperidol by toposelective recording from different brain structures in the immobilized rat (stereo-EEG). Neuropsychobiology (1985) 0.75
Memantine reduces repetitive action potential firing in spinal cord nerve cell cultures. Eur J Pharmacol (1990) 0.75
Description of healthy and disturbed sleep by means of the spectral frequency index (SFx) - a retrospective analysis. Eur J Med Res (2001) 0.75
[Neurotoxic actions of Clostridium tetani and botulinum toxins (proceedings)]. Zentralbl Bakteriol Orig A (1976) 0.75
Rat nerve cell cultures in pharmacology and toxicology. Arch Toxicol (1980) 0.75
Movement of labeled macromolecules to the goldfish optic tectum following intraocular injection of 125I-labelled tetanus toxin. Exp Neurol (1976) 0.75
Nervous system-specific protein D2 associated with neurite outgrowth in nerve cell cultures. J Neuroimmunol (1982) 0.75
Ganglioside therapy in experimental diabetic neuropathy. Arzneimittelforschung (1988) 0.75
[A new method for assessment of mental performance during simultaneous, quantitative, topographical electroencephalometry and psychometry in pharmacology. Proof of the effect of a combination of biogenic amines, vitamins, minerals and trace elements]. Arzneimittelforschung (1994) 0.75
A new frequency based automatic sleep analysis - description of the healthy sleep. Eur J Med Res (1997) 0.75
Explorations in Guatemala. Science (1884) 0.75
Can intravenous immunoglobulin improve antibody-mediated botulinum toxin therapy failure? Mov Disord (2000) 0.75